COVAX: The vaccines pillar of the access to COVID-19 tools (ACT) Accelerator
Overview
This document has been updated, please see the version posted on 5 December 2022 for the latest.
COVAX is the vaccines pillar of the ACT Accelerator, co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, and the World Health Organization (WHO). Its goal is to help end the acute phase of the global pandemic by the end of 2021 by providing access to at least 2 billion doses of safe and effective COVID-19 vaccines to the most vulnerable in all participating economies. If it succeeds in this goal, through the appropriate allocation of safe and effective doses of vaccines in phases determined by epidemiology and public health to slow and ultimately to stop the pandemic, it could save millions of lives and transform the economic prospects of governments and individuals.
The following document outlines the current working structure and overall guiding principles of collaboration between the organisations involved in implementing COVAX. Building on existing bodies wherever possible, and adapting to emerging needs, this working structure will continue to evolve as needed.